Oil Prices Are On A Nose-dive With Rising Supply Concerns

A negative demand outlook and US President Donald Trump’s Twitter critique of the world’s biggest crude exporter, deepened oil’s decline as investors fled a market by excess supplies. On Tuesday, Futures plunged 6 percent in both London and New York. At a time of steadily rising American production and stockpiles, OPEC’s dire forecast for 2019 demand came.

President Trump cautioned Saudi Arabia to mourn prices that dipped below $US57 a barrel for the first time since December and curb output in a matter of weeks. A senior commodities strategist at ING Bank ‘prices were not helped by this tweet’.  [optin-monster-shortcode id=”swikrbu1d9j9aq0o4cko”]

OPEC will likely try to ignore President Trump’s call as much as possible, given the growing global surplus over the first half of 2019. For a record 12 sessions on fears of a supply surplus, West Texas Intermediate futures have fallen.

To the lowest in 14 months as of November 6, money managers combined bullish positions in WTI and Brent sank, as long positions shrank and shorts increased commodity Futures Trading commission data show.

Adding to the shorts are the trend following guys and liquidating longs are global macro guys, getting a combination of the systematic CTAs. At 12.48pm WTI for December delivery dropped on the New York Mercantile Exchange to $US57.24 a barrel i.e. by $US2.69. While above the 100-day average, the Total volume traded Tuesday was almost 60 percent.

On the London-based ICE Futures Europe exchange, Brent futures for January settlement fell $US3.06 to $US67.06. The global benchmark crude for the same month traded at a $US9.73 premium to WTI.

John Kilduff, partner at Again Capital, sent a negative signal to the market in coming together to cut 1 million barrels, that unwillingness yesterday and over the weekend by Russia to participate. Since May 2017 early on Tuesday, the Bloomberg dollar spot Index touched the highest, before slipping back.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.


Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report